Stemtech (OTCMKTS: $STEK): Exploring The Future Of Stem Cell Nutrition

2024-01-22 82

John W. Meyer, President & COO, and Charles S. Arnold, Chairman & CEO of Stemtech Corporation were recently interviewed by Benzinga.

Stemtech is a pioneer in the “stemceuticals” space. The company creates and markets nutritional supplements it says help spur the body’s natural production of adult stem cells. Stem cells play an integral role in the body’s ability to heal itself and repair damaged tissues.

Stemtech has a successful direct marketing approach that it believes can help it continue to grow as public awareness of stem cells grows as well.

Free Traffic Exchange